Skip to main content
. 2012 Jul 28;12:317. doi: 10.1186/1471-2407-12-317

Table 3.

Five-year relative survival of breast cancer patients by age and stage

stage
Germany (Saarland)
US (SEER 9/13 regionsa)
 
 
1993-96
1997-00
2001-04
2005-08
Δ
p-value
1993-96
1997-00
2001-04
2005-08
Δ
p-value
    RS SE RS SE RS SE RS SE     RS SE RS SE RS SE RS SE    
overall
crude
73.0
1.1
77.1
1.0
80.1
0.9
84.2
0.9
11.2
<0.001
84.1
0.2
86.3
0.2
88.2
0.1
88.6
0.1
4.5
<0.001
 
age std b
72.2
1.3
76.3
1.2
79.0
1.1
82.5
1.0
10.3
<0.001
84.2
0.2
86.3
0.2
88.2
0.2
88.1
0.2
3.9
<0.001
 
stage mix std c
78.8
1.1
82.3
0.9
85.3
0.8
87.9
0.7
9.1
<0.001
84.1
0.2
85.7
0.1
87.7
0.1
88.1
0.1
4.0
<0.001
 
15-49 years
75.4
2.0
78.6
1.8
83.9
1.6
87.7
1.4
12.3
<0.001
82.8
0.3
85.2
0.3
87.3
0.2
89.2
0.2
6.4
<0.001
 
50-69 years
74.7
1.4
79.1
1.3
81.7
1.1
88.6
1.0
14.0
<0.001
85.4
0.2
87.5
0.2
89.8
0.2
90.0
0.2
4.7
<0.001
 
15-69 years
74.9
1.2
78.9
1.0
82.3
0.9
88.4
0.8
13.5
<0.001
84.4
0.2
86.7
0.2
88.9
0.1
89.7
0.1
5.3
<0.001
 
> = 70 years
69.3
2.4
73.6
2.2
75.1
2.1
74.9
2.1
5.6
0.026
83.6
0.4
85.5
0.4
86.5
0.4
85.7
0.4
2.1
0.001
localized
crude
90.7
1.5
93.3
1.2
96.0
1.0
97.5
0.9
6.8
0.002
95.4
0.2
96.1
0.2
97.0
0.2
97.2
0.1
1.8
<0.001
 
age std b
91.4
2.4
94.5
1.9
97.4
1.6
98.7
1.4
7.3
<0.001
95.7
0.2
96.3
0.2
97.3
0.2
97.3
0.2
1.6
<0.001
 
15-49 years
86.9
2.5
92.3
1.9
93.1
1.6
95.3
1.4
8.4
0.011
93.6
0.3
94.1
0.2
95.4
0.2
96.3
0.2
2.7
<0.001
 
50-69 years
91.7
1.8
91.6
1.5
95.4
1.2
98.7
0.9
7.0
0.001
95.4
0.2
96.4
0.2
97.4
0.2
97.6
0.2
2.2
<0.001
 
15-69 years
90.1
1.5
91.8
1.2
94.7
0.9
97.8
0.7
7.7
<0.001
94.8
0.2
95.6
0.1
96.8
0.1
97.2
0.1
2.4
<0.001
 
> = 70 years
93.2
4.6
98.3
3.5
99.9
2.9
96.6
2.9
3.4
0.555
96.7
0.5
97.0
0.4
97.5
0.4
97.4
0.4
0.7
0.290
 
T1 age std b
97.3
4.0
99.3
2.9
99.5
2.4
104.1
1.8
6.8
-
98.8
0.3
99.5
0.2
99.9
0.2
100.4
0.2
1.7
-
 
T2-3 age std b
89.4
3.7
92.1
2.9
93.9
2.4
92.1
2.4
2.7
0.110
86.3
0.6
87.0
0.5
89.7
0.5
89.3
0.5
3.0
<0.001
local/regional spread
crude
65.2
1.8
70.9
1.7
76.4
1.5
81.1
1.5
15.9
<0.001
75.8
0.4
79.0
0.3
83.3
0.3
85.0
0.3
9.2
<0.001
 
age std b
64.0
2.2
70.3
2.0
74.8
1.9
78.6
1.8
14.6
<0.001
75.1
0.4
77.5
0.4
81.7
0.4
82.8
0.4
7.6
<0.001

15-49 years
70.7
3.4
71.4
3.1
81.1
2.7
82.6
2.6
11.9
0.004
75.5
0.6
80.2
0.5
83.5
0.4
86.8
0.4
11.3
<0.001
 
50-69 years
65.3
2.5
72.2
2.2
77.6
1.9
86.2
1.7
20.8
<0.001
78.1
0.5
80.6
0.4
86.3
0.3
87.1
0.3
9.1
<0.001
 
15-69 years
66.9
2.0
71.9
1.8
78.6
1.6
85.1
1.4
18.2
<0.001
76.9
0.4
80.4
0.3
85.2
0.3
87.0
0.2
10.0
<0.001
 
> = 70 years
61.1
4.0
68.7
3.7
70.5
3.7
70.8
3.6
9.7
0.084
72.4
0.9
74.3
0.8
76.7
0.8
77.5
0.8
5.1
<0.001
 
T1/2 age std b
73.0
3.1
79.3
2.7
84.4
2.4
85.6
2.2
12.6
<0.001
81.4
0.5
83.6
0.5
87.7
0.4
88.1
0.4
6.7
<0.001
 
T3/4 age std b
47.1
3.6
52.3
3.5
56.2
3.4
64.3
3.2
17.2
<0.001
64.3
1.0
68.1
0.9
71.7
0.8
68.8
0.8
4.5
0.001
distant metastasis
crude
20.2
3.0
21.9
3.0
20.1
2.6
23.0
3.0
2.8
0.111
21.2
0.7
24.1
0.7
27.2
0.7
29.2
0.7
7.9
<0.001
 
age std b
20.3
3.2
22.1
3.0
19.0
2.6
23.7
3.0
3.3
0.106
20.2
0.7
22.5
0.7
25.2
0.7
26.7
0.7
6.5
<0.001
 
15-49 years
11.5
5.8
17.9
8.9
26.9
7.6
29.6
9.1
18.2
0.029
26.8
1.5
31.5
1.4
34.5
1.4
38.8
1.4
11.9
<0.001
 
50-69 years
25.3
4.4
24.7
4.4
23.6
4.0
29.1
4.6
3.8
0.237
21.3
1.0
24.4
1.0
29.0
1.0
30.5
1.0
9.2
<0.001
 
15-69 years
22.0
3.7
23.9
3.9
24.5
3.5
28.5
4.1
6.5
0.058
23.2
0.9
26.9
0.8
30.9
0.8
33.2
0.8
10.0
<0.001
 
> = 70 years
17.2
5.9
19.3
4.7
13.3
3.7
15.3
4.2
−1.9
0.712
17.4
1.1
18.2
1.1
19.0
1.1
19.4
1.1
2.1
0.045
unknown stage
crude
78.4
2.5
81.3
2.8
77.0
3.5
81.4
2.8
3.0
0.381
55.2
1.2
57.7
1.2
55.0
1.4
43.5
1.5
−11.7
<0.001
  age std b 78.7 2.5 82.1 2.7 77.6 3.2 82.7 2.5 4.0 0.084 55.6 1.3 59.0 1.2 56.1 1.5 45.2 1.6 −10.4 <0.001

Five-year relative survival of female patients with invasive breast cancer (ICD-10 code: C50) from Germany (Saarland) and the US (SEER 9/13 regions) by age and stage for successive calendar periods.

RS: relative survival (period estimate) in %; SE: standard error; std: standardized; Δ : difference of RS between 2005–08 and 1993–96 in % units; a the coverage of SEER program was extended from 9 to 13 registries in 1992; b using weights from the International Cancer Survival Standards [33]; c weights derived from the SEER patients diagnosed 1988–2008.